Exendin-4 Rabbit Polyclonal Antibody
CAT#: TA364338
Rabbit polyclonal anti Exendin-4, purified IgG
Need it in bulk or conjugated?
Get a free quote
CNY 11,419.00
货期*
5周
规格
Product images
经常一起买 (1)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
CNY 300.00
CNY 1,430.00
Specifications
Product Data | |
Applications | ELISA |
Recommend Dilution | This antibody has been tested and validated in ELISA against Exendin- 4. Other applications like immunohistochemistry (IHC), FACS or Western Blot may work as well. Optimal dilutions should be determined by the end user. |
Reactivity | Human, Mammalian |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | Synthetic peptide H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys- Gln-Met-Glu-GluGlu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly- Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 coupled to a carrier protein. |
Formulation | Protein A affinity purified from antiserum, lyophilized, packaged under nitrogen. Reconstitute by adding 0.2ml distilled water. This stock solution contains 2mg/ml IgG, phosphate buffer saline pH 7.4 (PBS), and 0.02% (w/v) Thimerosal as a preservative. |
Concentration | N/A |
Conjugation | Unconjugated |
Storage Condition | Original vial: at least one year at 4° - 8°C from date of delivery. Minimize repeated thawing and freezing of the antiserum by freezing aliquots at -20°C or below. |
Background | Exendin-4 is a 39 amino acid peptide amide known to be a long-acting agonist of the glucagon-like peptide 1 receptor (GLP-1). It is involved in glucose-dependent enhancement of insulin secretion, reduction of hyperglycemia, and glucose- dependent suppression of high glucagon secretion. Exendin-4 is used as active component of Byetta® (exenatide) injection, which may improve glycemic control in people with type 2 diabetes mellitus. This antibody was generated by immunization of rabbits with Exendin-4 coupled to a carrier protein. |
Reference Data |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
其它Exendin-4产品
Customer
Reviews
Loading...